Is the Philippines Gearing Up to Mass Produce Ivermectin for COVID-19? Their FDA Awards Ivermectin Manufacturing Contract to Local Producer

Is the Philippines Gearing Up to Mass Produce Ivermectin for COVID-19 Their FDA Awards Ivermectin Manufacturing Contract to Local Producer

Apparently, in the Philippines, the use of ivermectin for human consumption (more than likely associated with SARS-CoV-2, the virus behind COVID-19) is progressing despite the overt tensions between those elements in society for its use against COVID-19 now versus those that suggest ever more clinical trials data is necessary. This movement is evidenced recently by the movement within the Philippines Food and Drug Administration (FDA) as Director-General Eric Domingo  just on Friday acknowledged that the regulatory body issued a certificate of product registration or CPR to Lloyd Laboratories for the production and commercial sale of the product in the southeastern Asian nation. Meaning that the FDA there is paving the way for its legal human consumption. Of course, the formal indication is acknowledged by Director-General Domingo as a “…antinematode drug,” meaning a type of parasitic worm but what’s interesting is the timing. The Philippines agency’s formal move, according to a text message recently, more than likely correlates with the latest wave in COVID-19 cases and fear associated with what’s going on in places such as India.

According to CNN Philippines Lloyd Laboratories was one of two local firms that had expressed to register with the FDA to produce the generic drug: Pascual Laboratories was the other companies.

CNN Philippines noted that ivermectin isn’t registered in the country for the prevention of COVID-19 yet the FDA has already issued six compassionate use permits to hospitals seeking to use the drug for sick COVID-19 patients.

Lloyd Laboratories

Quezon City-based Lloyd Laboratories is a pharmaceutical manufacturing company based in the Philippines. Launched back in 1989, they have become the major pharmaceutical manufacturing companies in the Philippines with operations also in Indonesia and India. The company focuses on the production of capsules, liquid orals, ointments, dry powder inhalers and nasal spray formulations with GcP (e.g. FDA compliance) norms.

With a production facility in Malolos City, Bulacan, Philippines, they also operate in Tangerang, Indonesia and Chennai and Pondicherry, India, with a total of over 500,000 square feet of space.

The company was founded by Zenaida Balajadia, a businessman that was in food milling and production going back as far as 1976. This was a family business.


  1. they approved at least six hospitals for compassionate use of ivermectin for covid-19, but so far the hospitals do not want to be named by the press.